<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://veterinaryrecord.bmj.com">
<title>Veterinary Record Research</title>
<link>http://veterinaryrecord.bmj.com</link>
<description>Veterinary Record RSS feed -- recent Research articles</description>
<prism:eIssn>2042-7670</prism:eIssn>
<prism:publicationName>Veterinary Record</prism:publicationName>
<prism:issn>0042-4900</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/20/524?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/20/526?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/20/527?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/20/528?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/20/529?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/20/529-a?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/19/459?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/19/501?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/19/502?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/19/503?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/19/504?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/19/504-a?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/18/470?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/18/472?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/18/473?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/18/474?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/18/475?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/18/475-a?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/17/447?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/17/449?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/17/450?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/17/451?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/17/452?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/17/452-a?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/16/421?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/16/423?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/16/424?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/16/425?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/16/426?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/16/426-a?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/15/393?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/15/395?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/15/396?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/15/397?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/15/398?rss=1" />
  <rdf:li rdf:resource="http://veterinaryrecord.bmj.com/cgi/content/short/172/15/398-a?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://veterinaryrecord.bmj.com/site/homepage/VETREC_95x60.gif" />
</channel>
<image rdf:about="http://veterinaryrecord.bmj.com/site/homepage/VETREC_95x60.gif">
<title>Veterinary Record</title>
<url>http://veterinaryrecord.bmj.com/site/homepage/VETREC_95x60.gif</url>
<link>http://veterinaryrecord.bmj.com</link>
</image>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/20/524?rss=1">
<title><![CDATA[Developing less invasive surgery to help manage reproduction in reptiles]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/20/524?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>A RESULT of the increasing significance and improvement of veterinary care for reptiles, kept both by professional zoological gardens and private breeders, is that veterinary surgeons who specialise in reptile reproduction have to meet more and more demanding requirements. These are comparable with the demands placed on human physicians or veterinarians caring for dogs and cats. This is illustrated by the development of diagnostic techniques that use various modifications of classical rigid endoscopic methods. These methods have made it possible for veterinarians to develop reliable and safe techniques of biopsy of organs such as the liver and kidneys (Hernandez-Divers and others 2005). The samples taken in this way and processed by histological techniques can be used to assess the extent and form of damage of vital organs and make a correct diagnosis and objective prognosis.</p> <p>To be most useful, clinical diagnostics must be reliable and fast. At...]]></description>
<dc:creator><![CDATA[Knotek, Z.]]></dc:creator>
<dc:date>2013-05-17T06:20:52-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.f3060</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.f3060</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Developing less invasive surgery to help manage reproduction in reptiles]]></dc:title>
<prism:publicationDate>2013-05-18</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>20</prism:number>
<prism:startingPage>524</prism:startingPage>
<prism:endingPage>525</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/20/526?rss=1">
<title><![CDATA[Coelioscopic orchiectomy can be effectively and safely accomplished in chelonians]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/20/526?rss=1</link>
<description><![CDATA[
<p>Coelioscopic orchiectomy was performed in 27 male turtles (25 juvenile to adult red-eared sliders (<I>Trachemys scripta elegans</I>), one adult eastern painted turtle (<I>Chrysems picta picta</I>), and one juvenile male yellow-spotted Amazon River turtle (<I>Podocnemis unifilis</I>)). Orchiectomy was conducted under coelioscopic visualisation using ligation and transection of the mesorchium, or transection of the mesorchium with monopolar radiosurgical scissors. In 22 cases, bilateral orchiectomy was performed through a single incision; five turtles required bilateral incisions. All turtles recovered from anaesthesia. Nine turtles died within one year of surgery from conditions believed to be unrelated to surgery. One turtle was lost to follow-up. Seventeen turtles remain clinically healthy one to three years postoperatively. Coelioscopic orchiectomy provides a minimally invasive method for sterilisation of male chelonians and provides excellent visualisation during surgery. This technique is a useful model for the development of additional minimally invasive surgical techniques for chelonians.</p>
]]></description>
<dc:creator><![CDATA[Innis, C. J., Feinsod, R., Hanlon, J., Stahl, S., Oguni, J., Boone, S., Schnellbacher, R., Cavin, J., Divers, S. J.]]></dc:creator>
<dc:date>2013-05-17T06:20:52-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101475</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101475</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Coelioscopic orchiectomy can be effectively and safely accomplished in chelonians]]></dc:title>
<prism:publicationDate>2013-05-18</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>20</prism:number>
<prism:startingPage>526</prism:startingPage>
<prism:endingPage>526</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/20/527?rss=1">
<title><![CDATA[Meningoencephalitis of unknown origin: investigation of prognostic factors and outcome using a standard treatment protocol]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/20/527?rss=1</link>
<description><![CDATA[
<p>Meningoencephalitis of unknown origin (MUO) is a common inflammatory CNS disease in dogs, with a variable and unpredictable outcome. MRI and cerebrospinal fluid (CSF) features were prospectively evaluated to establish their utility as prognostic markers for predicting mortality, relapse and long-term outcome in 39 dogs with MUO. MRI and CSF analysis were performed at initial diagnosis and three months into treatment with prednisolone and cytosine arabinoside. When possible, MRI was repeated every 12&nbsp;months thereafter. Median survival time was 26&nbsp;days. All deaths occurred within 52&nbsp;days of diagnosis (22/39; 56 per cent). One-third (13/39) died within 72&nbsp;hours of diagnosis. Outcome was good or excellent in 12/17 surviving dogs. Loss of the cerebral sulci and foramen magnum herniation on MRI were associated with increased risk of mortality. An abnormal CSF analysis at the three-month re-examination was associated with increased risk of relapse (P=0.04). The combination of MRI and CSF analysis provided a greater sensitivity for predicting relapse than one modality alone. Discontinuing treatment before MRI lesions resolved always resulted in relapse. The presence of certain MRI characteristics may indicate an increased risk of mortality. Dogs alive three months following diagnosis have a very low risk of death due to MUO.</p>
]]></description>
<dc:creator><![CDATA[Lowrie, M., Smith, P. M., Garosi, L.]]></dc:creator>
<dc:date>2013-05-17T06:20:52-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101431</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101431</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Meningoencephalitis of unknown origin: investigation of prognostic factors and outcome using a standard treatment protocol]]></dc:title>
<prism:publicationDate>2013-05-18</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>20</prism:number>
<prism:startingPage>527</prism:startingPage>
<prism:endingPage>527</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/20/528?rss=1">
<title><![CDATA[The effect of lactic acidosis on the generation and compensation of mixed respiratory-metabolic acidosis in neonatal calves]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/20/528?rss=1</link>
<description><![CDATA[
<p>Postnatal mixed respiratory-metabolic acidosis is common in calves, and depending on its severity can impair vitality or even cause death. Carbon dioxide accounts for the respiratory component and L-lactate for the metabolic component of the mixed acidosis, but it remains unclear which component determines the severity and duration of the acidosis. In a first attempt to clarify, this was investigated retrospectively in 31 calves during the first two hours of life, and in 13 calves during the first three days of life. Venous blood was collected for blood gas analysis and measurement of acid-base variables and L-lactate concentration. pH Was more strongly correlated with L-lactate concentration (r<sup>2</sup>=0.808) than with partial pressure of CO<SUB>2</SUB> (pCO<SUB>2</SUB>, r<sup>2</sup>=0.418). Duration of parturition had a distinct effect on pH and L-lactate concentration but not on pCO<SUB>2</SUB>; calves born within six hours of rupture of the allantoic sac had a higher pH and lower L-lactate concentration than calves born after a longer duration of parturition (both P&lt;0.01). Normalisation of pCO<SUB>2</SUB> took four&nbsp;hours and normalisation of L-lactate took 48&nbsp;hours. It was concluded that L-lactate is a more important factor in the pathogenesis of acidosis than pCO<SUB>2</SUB>, and that the duration of metabolic acidosis exceeds that of respiratory acidosis in perinatal asphyxia of calves.</p>
]]></description>
<dc:creator><![CDATA[Bleul, U., Gotz, E.]]></dc:creator>
<dc:date>2013-05-17T06:20:52-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101192</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101192</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[The effect of lactic acidosis on the generation and compensation of mixed respiratory-metabolic acidosis in neonatal calves]]></dc:title>
<prism:publicationDate>2013-05-18</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>20</prism:number>
<prism:startingPage>528</prism:startingPage>
<prism:endingPage>528</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/20/529?rss=1">
<title><![CDATA[Germline polymorphism at the {beta}2-microglobulin exon 1/intron 1 splice site in canine mammary gland simple and complex carcinomas]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/20/529?rss=1</link>
<description><![CDATA[ <p>&beta;2-Microglobulin (&beta;<I>2M</I>) forms the invariant chain of major histocompatibility complex (MHC) class I molecules and is essential for their structural stability and optimal functioning (Pedersen and others 1994). Loss or downregulation of MHC class I expression has been reported in various types of cancer (Chang and others 2003, Aptsiauri and others 2007). In human beings, mutations in &beta;<I>2M</I> are a significant mechanism for the total loss of MHC class I, and &beta;<I>2M</I> mutations have been described in colon carcinomas, melanomas and lymphomas. The mutational hot spot in &beta;<I>2M</I> mutations is exon 1 (Garrido and others 1997, P&eacute;rez and others 1999), although no such mutations have been identified in breast cancers (Chen and others 1996). Several point mutations have been identified in &beta;<I>2M</I> in healthy domestic dogs, and the data have been deposited in the Broad Institute Dog Genome Project database (CanFam2.0&mdash;2,544,508 SNPs; <A HREF="http://dx.doi.org/http://www.broadinstitute.org/mammals/dog">http://www.broadinstitute.org/mammals/dog</A>). However, almost all known...]]></description>
<dc:creator><![CDATA[Tanaka, T., Shimada, T., Akiyoshi, H., Zheng, C., Mie, K., Yijyun, L., Hayashi, A., Ohashi, F.]]></dc:creator>
<dc:date>2013-05-17T06:20:52-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101238</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101238</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Germline polymorphism at the {beta}2-microglobulin exon 1/intron 1 splice site in canine mammary gland simple and complex carcinomas]]></dc:title>
<prism:publicationDate>2013-05-18</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>20</prism:number>
<prism:startingPage>529</prism:startingPage>
<prism:endingPage>529</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/20/529-a?rss=1">
<title><![CDATA[Clinical and biochemical consequences of soybean meal intoxication in cattle]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/20/529-a?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>A 2 per cent bodyweight acute soybean meal (SBM) intoxication was recently described in steers (Raboisson and others 2012). It induced a decrease in ruminal pH followed by an increase in ruminal ammonia, and blood metabolic alkalosis with hyperuraemia, severe hyperammonaemia and hyperglycaemia. This report describes the epidemiology, clinical signs (CS) and biochemical modifications observed during accidental SBM intoxication.</p> <p>Thirty-nine Holstein cows were housed in loose yarding with a straw lying area. Mean annual and daily production was around 7000 and 25&nbsp;litres of milk per cow, respectively. The diet consisted of corn silage, SBM and commercial concentrates. One tonne of SBM was accidently poured on the straw area (25&nbsp;kg per cow on average) between 14:00 and 18:00 on day 0 (D0). During the evening, the farmer administered 300&ndash;400&nbsp;g of NaHCO<SUB>3</SUB> powder orally, once, to cows 1&ndash;5.</p> <p>Cows 1&ndash;3 died during the night D0&ndash;D1 (<cross-ref type="tbl" refid="VETREC2012101468TB1">Table&nbsp;1</cross-ref>). In...]]></description>
<dc:creator><![CDATA[Raboisson, D., Ferrieres, A., Cousinie, P., Schelcher, F.]]></dc:creator>
<dc:date>2013-05-17T06:20:52-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101468</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101468</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Clinical and biochemical consequences of soybean meal intoxication in cattle]]></dc:title>
<prism:publicationDate>2013-05-18</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>20</prism:number>
<prism:startingPage>529</prism:startingPage>
<prism:endingPage>529</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/19/459?rss=1">
<title><![CDATA[Dynamic endoscopy of the equine upper airway - what is significant?]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/19/459?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>DYNAMIC upper respiratory collapse is a common cause of poor performance in horses (Dart and others 2001, Parente and others 2002, Tan and others 2005, Lane and others 2006). Dynamic endoscopy of the upper respiratory tract allows the identification of various obstructive conditions that endoscopy at rest is unable to identify. Until recently, this has only been achievable using high speed treadmill endoscopy (HSTE). This technique has allowed the identification of numerous obstructive conditions, including recurrent laryngeal neuropathy, intermittent dorsal displacement of the soft palate, axial deviation of the aryepiglottic folds, vocal fold collapse and, more recently, ventroaxial luxation of the apex of the corniculate process of the arytenoid cartilage (<cross-ref type="bib" refid="VETRECF2934C14">Kannegieter and Dore 1995</cross-ref>, Dart and others 2001, 2005, Parente and others 2002, Tan and others 2005, Lane and others 2006, Davidson and others 2011). Some of the main criticisms of HSTE include an inability...]]></description>
<dc:creator><![CDATA[Trope, G.]]></dc:creator>
<dc:date>2013-05-10T06:50:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.f2934</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.f2934</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Dynamic endoscopy of the equine upper airway - what is significant?]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>19</prism:number>
<prism:startingPage>459</prism:startingPage>
<prism:endingPage>500</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/19/501?rss=1">
<title><![CDATA[Dynamic ventrorostral displacement of the dorsal laryngeal mucosa in horses]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/19/501?rss=1</link>
<description><![CDATA[
<p>The objectives of this report were to describe the occurrence and features of dynamic ventrorostral displacement of the dorsal laryngeal mucosa (VRDDLM) in a group of Thoroughbred horses presented for investigation of poor performance and/or abnormal respiratory noise. Records from 600, dynamic, endoscopic examinations of the upper respiratory tract of horses were reviewed. Horses with VRDDLM were identified as those in which the dorsal laryngeal mucosa progressively obscured the interarytenoid notch and dorsoaxial portion of the corniculate processes of the arytenoid cartilages during high-speed exercise. The condition was recognised in 12 horses. Concurrent abnormalities of the respiratory tract of eight horses were also identified and included, axial deviation of the aryepiglottic folds, vocal cord prolapse, unilateral and bilateral ventromedial luxation of the apex of the corniculate process of the arytenoid cartilage, and intermittent dorsal displacement of the soft palate. VRDDLM is a rare abnormality of the upper portion of the respiratory tract of horses that may be associated with abnormal respiratory noise and potentially poor performance. The significance of the condition is not known, but the presence of this condition in combination with other, obstructive diseases of the equine airway warrants further investigation.</p>
]]></description>
<dc:creator><![CDATA[Pollock, P. J., Kelly, P. G., Reardon, R. J. M., Kelly, G. M.]]></dc:creator>
<dc:date>2013-05-10T06:50:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101319</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101319</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Dynamic ventrorostral displacement of the dorsal laryngeal mucosa in horses]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>19</prism:number>
<prism:startingPage>501</prism:startingPage>
<prism:endingPage>501</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/19/502?rss=1">
<title><![CDATA[Diagnosis algorithm for leptospirosis in dogs: disease and vaccination effects on the serological results]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/19/502?rss=1</link>
<description><![CDATA[
<p>Leptospirosis is a common disease in dogs, despite their current vaccination. Vet surgeons may use a serological test to verify their clinical observations. The gold standard is the Microscopic Agglutination Test (MAT). After infection, the dog produces agglutinating antibodies against the lipopolyosidic antigens shared by the infectious strain but also, after vaccination, against the lipopolyosidic antigens shared by the serovars used in the bacterins (<I>Leptospira</I> species serovars Icterohaemorrhagiae and Canicola in most countries). MATs were performed in a group of 102 healthy field dogs and a group of 6 Canicola-challenged dogs. A diagnosis algorithm was constructed based on age, previous vaccinations, kinetics of the agglutinating antibodies after infection or vaccination and the delay after onset of the disease. This algorithm was applied to 169 well-documented sera (clinical and vaccine data) from 272 sick dogs with suspected leptospirosis. Totally, 102 dogs were vaccinated according to the usual vaccination scheme and 30 were not vaccinated. Leptospirosis was confirmed by MAT in 37/102 (36.2 per cent) vaccinated dogs and remained probable in 14 others (13.7 per cent), thus indicating the permanent exposure of dogs and the weakness of the protection offered by the current vaccines to pathogenic <I>Leptospira</I>.</p>
]]></description>
<dc:creator><![CDATA[Andre-Fontaine, G.]]></dc:creator>
<dc:date>2013-05-10T06:50:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101333</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101333</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Diagnosis algorithm for leptospirosis in dogs: disease and vaccination effects on the serological results]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>19</prism:number>
<prism:startingPage>502</prism:startingPage>
<prism:endingPage>502</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/19/503?rss=1">
<title><![CDATA[Farm animal practitioners' views on their use and expectations of veterinary diagnostic laboratories]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/19/503?rss=1</link>
<description><![CDATA[
<p>Diagnostic sampling of farm animals by private veterinary practitioners can be an important contributing factor towards the discovery of emerging and exotic diseases. This focus group study of farm animal practitioners in Northern Ireland investigated their use and expectations of diagnostic veterinary laboratories, and elicited their opinions on the role of the private practitioner in veterinary surveillance and the protection of rural public health. The veterinarians were enthusiastic users of diagnostic laboratories, and regarded their own role in surveillance as pivotal. They attached great importance to their veterinary public health duties, and called for more collaboration with their medical general practitioner counterparts. The findings of this research can be used to guide future development of veterinary diagnostic services; provide further insights into the mechanics of scanning surveillance; and measure progress towards a &lsquo;One Health&rsquo; approach between veterinarians and physicians in one geographical region of the UK.</p>
]]></description>
<dc:creator><![CDATA[Robinson, P. A., Epperson, W. B.]]></dc:creator>
<dc:date>2013-05-10T06:50:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101366</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101366</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Farm animal practitioners' views on their use and expectations of veterinary diagnostic laboratories]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>19</prism:number>
<prism:startingPage>503</prism:startingPage>
<prism:endingPage>503</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/19/504?rss=1">
<title><![CDATA[Diagnosis and management of perineurial (Tarlov) cysts in two dogs]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/19/504?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>Case 1. A 10-year-old female intact German shepherd dog, presented with a six-month history of progressive neck pain and ataxia of all four limbs. Neurological examination was consistent with a C1-C5 myelopathy. Atlanto-occipital cisternal cerebrospinal fluid (CSF) analysis was unremarkable.</p> <p>MRI of the neck using a 1.5&nbsp;T magnet (Echospeed; GE Medical Systems) revealed degeneration of the C5-C6 intervertebral disc with mild dorsal protrusion causing mild right-sided ventro-lateral spinal cord compression; additionally, a 5&nbsp;mm<FONT FACE="arial,helvetica">x</FONT>6&nbsp;mm<FONT FACE="arial,helvetica">x</FONT>7&nbsp;mm oval cystic structure dorsolateral to the spinal cord was noted, causing moderate right-sided dorso-lateral spinal compression at the same level. This lesion was T2 hyperintense, T1 hypointense, T2 FLAIR hypointense (all when compared with the spinal cord) and non-contrast enhancing.</p> <p>A right-sided dorsal laminectomy was performed at C5-C6. The cystic lesion, originating from the dorsal nerve root lateral to the dorsal root ganglion, was fenestrated and a biopsy was obtained, taking care to avoid...]]></description>
<dc:creator><![CDATA[Liebel, F.-X., Platt, S., Matiasek, K., Houlton, J., Garosi, L.]]></dc:creator>
<dc:date>2013-05-10T06:50:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101213</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101213</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Diagnosis and management of perineurial (Tarlov) cysts in two dogs]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>19</prism:number>
<prism:startingPage>504</prism:startingPage>
<prism:endingPage>504</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/19/504-a?rss=1">
<title><![CDATA[An observational study involving ewe postmortem examination at a fallen stock collection centre to inform flock health interventions]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/19/504-a?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>Effective sheep flock health plans must be underpinned by flock-specific diagnostic information and should make use of wider national flock health information. However, information on disease prevalence at flock level is often incomplete. This is despite the fact that protocols to diagnose common sheep diseases are well established and cost effective.</p> <p>Annual ewe mortality rates in the UK are estimated at 3&ndash;8 per cent (Johnston and others 1980, Scott 2007). The profile of diseases which contribute to mortality and involuntary culling in adult ewes in the UK flock is at present probably best estimated using Veterinary Investigation Diagnosis Analysis (VIDA) data (Gibbens and others 2008). This is generated by the Animal Health Veterinary Laboratories Agency (AHVLA) endemic disease scanning surveillance programme, which examines 500&ndash;700 ewes annually (VIDA 2012). However, the sample size, especially for carcases, is small, and the programme may have inherent biases (Nevel and Stark...]]></description>
<dc:creator><![CDATA[Lovatt, F. M., Strugnell, B. W.]]></dc:creator>
<dc:date>2013-05-10T06:50:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101628</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101628</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[An observational study involving ewe postmortem examination at a fallen stock collection centre to inform flock health interventions]]></dc:title>
<prism:publicationDate>2013-05-11</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>19</prism:number>
<prism:startingPage>504</prism:startingPage>
<prism:endingPage>504</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/18/470?rss=1">
<title><![CDATA[Epidemiology of parasitic gastroenteritis in beef suckler herds]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/18/470?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>The supply and use of veterinary anthelmintic and flukicide products in production animals is currently under scrutiny, in view of the concerns about the development of anthelmintic and flukicide resistance. A recent position statement from the Federation of Veterinarians of Europe (<cross-ref type="bib" refid="VETRECF2713C4">FVE 2013</cross-ref>) makes several recommendations to contain resistance, including that all anthelmintic products for food-producing animals should only be available via a veterinary prescription, such that their use is conditional on appropriate veterinary advice; that veterinarians have a role in promoting responsible use of anthelmintics; and that veterinarians and farmers need to work out integrated worm control programmes based on targeted strategic treatments rather than mass treatments.</p> <p>While the rationale behind these recommendations could be questioned, the subject of responsible use of anthelmintics is important and serves to emphasise that veterinarians working with food-producing species must have a sound knowledge of both product availability...]]></description>
<dc:creator><![CDATA[Forbes, A. B., Ellis, K. A.]]></dc:creator>
<dc:date>2013-05-03T05:50:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.f2713</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.f2713</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Epidemiology of parasitic gastroenteritis in beef suckler herds]]></dc:title>
<prism:publicationDate>2013-05-04</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>18</prism:number>
<prism:startingPage>470</prism:startingPage>
<prism:endingPage>471</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/18/472?rss=1">
<title><![CDATA[Calving season is a stronger determinant of worm burdens in pasture-based beef production than the level of residual larval contamination at turnout]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/18/472?rss=1</link>
<description><![CDATA[
<p>The combined influence of (1) calving period (early or late) and (2) overwintering contamination by residual infective larvae (high or low) on subsequent exposure of suckler calves to gastrointestinal nematodes was investigated. We found that the effect of calving date was greater than the level of residual contamination. This was because the adult cows produced large quantities of manure containing small amounts of nematode eggs from turnout, which significantly contaminated the pasture, and thereby, reduced the effect of prior high-low contamination. Early born calves were found to be more heavily exposed to parasites, most likely due to ingesting more herbage than those born later. Late-born calves also had relatively high antibody levels at turnout, which first decreased and then increased again. We suggest that the high antibody levels at turnout reflect passive transfer of maternal antibodies through the milk. There was also a significant difference in animal performance, with the more heavily exposed early born calves having significantly lower daily weight gain than the late-born calves. However, this might not be entirely due to increased parasitism.</p>
]]></description>
<dc:creator><![CDATA[Hoglund, J., Hessle, A., Dahlstrom, F.]]></dc:creator>
<dc:date>2013-05-03T05:50:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101077</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101077</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:subject><![CDATA[Open access]]></dc:subject>
<dc:title><![CDATA[Calving season is a stronger determinant of worm burdens in pasture-based beef production than the level of residual larval contamination at turnout]]></dc:title>
<prism:publicationDate>2013-05-04</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>18</prism:number>
<prism:startingPage>472</prism:startingPage>
<prism:endingPage>472</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/18/473?rss=1">
<title><![CDATA[Decline in human dog-bite cases during a street dog sterilisation programme in Jaipur, India]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/18/473?rss=1</link>
<description><![CDATA[
<p>Human dog-bite injuries are a major public health problem, particularly where there are large populations of free-roaming or street dogs. Dog bites are also the major source of human rabies infections. There is little information on the means to reduce these injuries. Monthly human animal-bite injury records from January 2003 to June 2011 were obtained from the main government hospital in Jaipur, India. The data were analysed and compared with records of pregnancy in street dogs in Jaipur obtained from a street dog sterilisation programme. Human animal-bite injuries showed a seasonal pattern which followed by approximately 10 weeks the seasonal peak of street dog breeding. The number of human animal bites has declined significantly since 2003. It is concluded that a street dog&nbsp;sterilisation programme can reduce human dog-bite injuries by reducing the maternal protective behaviour of the street dogs, as well as reducing the total size of the roaming dog&nbsp;population.</p>
]]></description>
<dc:creator><![CDATA[Reece, J. F., Chawla, S. K., Hiby, A. R.]]></dc:creator>
<dc:date>2013-05-03T05:50:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101079</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101079</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Decline in human dog-bite cases during a street dog sterilisation programme in Jaipur, India]]></dc:title>
<prism:publicationDate>2013-05-04</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>18</prism:number>
<prism:startingPage>473</prism:startingPage>
<prism:endingPage>473</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/18/474?rss=1">
<title><![CDATA[In vitro bactericidal activity of enrofloxacin against gyrA mutant and qnr-containing Escherichia coli isolates from animals]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/18/474?rss=1</link>
<description><![CDATA[
<p>The objective of this work was to investigate the bactericidal activity of enrofloxacin against <I>gyrA</I> mutant and <I>qnr-</I>containing <I>Escherichia coli</I> isolates from animals. The minimum inhibitory concentrations (MICs) of <I>gyrA</I> mutant and <I>qnr-</I>containing <I>E coli</I> isolates ranged from 1&nbsp;&micro;g/ml to 32&nbsp;&micro;g/ml for enrofloxacin. Time-kill experiments were performed using selected <I>E coli</I> isolates. For the time-kill experiments, the colony counts were determined by plating each diluted sample onto plate count agar and an integrated pharmacokinetic/pharmacodynamics area measure (log ratio area) was applied to the colony-forming units (cfu) data. In general, enrofloxacin exhibited bactericidal activity against all the <I>gyrA</I> mutant <I>E coli</I> isolates at all concentrations greater than four times the MIC. However, the bactericidal activity of enrofloxacin for all the <I>qnr</I>-containing <I>E coli</I> isolates was less dependent on concentration. The results of the present study indicated that the genetic mechanism of resistance might account for the different bactericidal activities of enrofloxacin observed for the <I>gyrA</I> mutant and the <I>qnr-</I>containing <I>E coli</I> isolates. Therefore, in addition to MIC assays, genetic mechanism-based pharmacodynamic models should be used to provide accurate predictions of the effects of drugs on resistant bacteria.</p>
]]></description>
<dc:creator><![CDATA[Cengiz, M., Sahinturk, P., Sonal, S., Buyukcangaz, E., Sen, A., Arslan, E.]]></dc:creator>
<dc:date>2013-05-03T05:50:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101331</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101331</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[In vitro bactericidal activity of enrofloxacin against gyrA mutant and qnr-containing Escherichia coli isolates from animals]]></dc:title>
<prism:publicationDate>2013-05-04</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>18</prism:number>
<prism:startingPage>474</prism:startingPage>
<prism:endingPage>474</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/18/475?rss=1">
<title><![CDATA[Detection of Agamid Adenovirus-1 in clinically healthy bearded dragons (Pogona vitticeps) in the UK]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/18/475?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>Pet reptiles are reported to be increasing in numbers with over 8 million captive in the UK alone (Federation of British Herpetologists data), with bearded dragons one of the most popular lizard species kept with numbers estimated to be in excess of 1 million. Agamid Adenovirus-1 (AAdV-1) infection was first reported in Australia in the early 1980s, and subsequently in the USA in the 1990s (Mitchell 2007). It spread through US populations and is now considered endemic (Mitchell 2007, Reavill and Griffin 2011). AAdV-1 is believed to be responsible for neurological symptoms, immunosuppression, reduced growth and death in infected bearded dragons, but many infected dragons may remain asymptomatic carriers, infecting offspring and in-contacts. As with many reptile viral infections, true pathogenicity is unclear with environmental factors and coinfections suspected to play a significant role in individual response (Marschang 2011).</p> <p>As development of new colour patterns and scalation...]]></description>
<dc:creator><![CDATA[Kubiak, M.]]></dc:creator>
<dc:date>2013-05-03T05:50:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101087</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101087</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Detection of Agamid Adenovirus-1 in clinically healthy bearded dragons (Pogona vitticeps) in the UK]]></dc:title>
<prism:publicationDate>2013-05-04</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>18</prism:number>
<prism:startingPage>475</prism:startingPage>
<prism:endingPage>475</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/18/475-a?rss=1">
<title><![CDATA[Ketamine-medetomidine regimen for chemical immobilisation of free-ranging chimpanzees (Pan troglodytes schweinfurthii) in Uganda]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/18/475-a?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>An increasing human population in Uganda has had consequences for free-ranging chimpanzees (<I>Pan troglodytes schweinfurthii</I>), including habitat destruction and antagonistic interaction with humans. This situation has led to increasing numbers of human-induced chimpanzee injuries, as well as elevated risks of pathogen transmission between these species. As a result, the need for veterinary intervention has increased commensurately.</p> <p>The most common form of human-induced injury in chimpanzees in Uganda is from snaring (Waller and Reynolds 2001). Other situations that may require intervention are disease outbreaks and orphaned individuals. For example, respiratory disease outbreaks of human metapneumovirus and respiratory syncytial virus have occurred in chimpanzees in West Africa and have had devastating effects (K&ouml;ndgen and others 2008). Interventions in such cases may be justified to provide treatment to the affected individuals and to obtain diagnostic specimens.</p> <p>In deciding whether to intervene, veterinarians consult with wildlife authorities and consider the risk...]]></description>
<dc:creator><![CDATA[Hyeroba, D., Apell, P., Goldberg, T., Shafer, L. A., Kidega, T., Asimwe, C.]]></dc:creator>
<dc:date>2013-05-03T05:50:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101336</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101336</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Ketamine-medetomidine regimen for chemical immobilisation of free-ranging chimpanzees (Pan troglodytes schweinfurthii) in Uganda]]></dc:title>
<prism:publicationDate>2013-05-04</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>18</prism:number>
<prism:startingPage>475</prism:startingPage>
<prism:endingPage>475</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/17/447?rss=1">
<title><![CDATA[Bovine viral diarrhoea virus: biology, diagnosis and control]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/17/447?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>BOVINE viral diarrhoea virus (BVDV) is an outstandingly successful virus. It is best known as the cause of a variety of clinical conditions resulting in economic losses in cattle, but understanding its biology has shown that BVDV and other pestiviruses have features unique among viruses.</p> <p>BVDV causes both transient and persistent infections and can escape the host's immune responses during both events. Transient infection occurs in cattle of all ages. Oronasal infection results in transient viraemia and virus excretion is low before it is eliminated by a standard immune response. The innate interferon response is followed by adaptive cell-mediated and humoral responses so that specific anti-BVDV antibody can be detected within three weeks of infection. Antibody levels continue to rise over the next two months and a solid immunity to that virus is maintained for years.</p> <p>However, if infection occurs in a pregnant animal, the virus escapes...]]></description>
<dc:creator><![CDATA[Nettleton, P.]]></dc:creator>
<dc:date>2013-04-26T07:30:51-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.f2526</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.f2526</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Bovine viral diarrhoea virus: biology, diagnosis and control]]></dc:title>
<prism:publicationDate>2013-04-27</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>17</prism:number>
<prism:startingPage>447</prism:startingPage>
<prism:endingPage>448</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/17/449?rss=1">
<title><![CDATA[Monitoring the bulk milk antibody response to BVDV: the effects of vaccination and herd infection status]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/17/449?rss=1</link>
<description><![CDATA[
<p>Bovine Viral Diarrhoea Virus (BVDV) is a pestivirus in the flaviviridae family which affects cattle worldwide. Bulk milk (BM) antibody testing is frequently used as a relatively quick method of assessing herd BVDV exposure; however, an understanding of the effects of vaccination and historic infection is essential for test interpretation. This study investigated the trends exhibited by monthly BM antibody analysis in 14 herds split into three categories. Category 1&nbsp;herds (vaccinating/no persistently infected (PI) animals) began the study with mid-positive BM antibody titres and experienced an estimated increase of 0.007 optical density (OD) units per month (equating to a rise of 0.35 OD units in 50&nbsp;months). Category 2 herds (not vaccinating/no PI animals) began the study with mid-positive BM antibody titres and experienced an estimated decrease of 0.005 OD units per month with antibody levels in one category 2 herd taking 1290&nbsp;days to decrease from mid-positive to negative. Category 3 herds (vaccinating/PI animals present) began the study with high BM antibody titres which plateaued within this range throughout the 50-month observation period. Vaccination was observed to cause transient increases in BM antibody in a number of herds in categories 1 and 3.</p>
]]></description>
<dc:creator><![CDATA[Booth, R. E., Cranwell, M. P., Brownlie, J.]]></dc:creator>
<dc:date>2013-04-26T07:30:51-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101195</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101195</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Monitoring the bulk milk antibody response to BVDV: the effects of vaccination and herd infection status]]></dc:title>
<prism:publicationDate>2013-04-27</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>17</prism:number>
<prism:startingPage>449</prism:startingPage>
<prism:endingPage>449</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/17/450?rss=1">
<title><![CDATA[Development and validation of an equine nerve block simulator to supplement practical skills training in undergraduate veterinary students]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/17/450?rss=1</link>
<description><![CDATA[
<p>Lameness is the most common presenting complaint in equine practice. Performing diagnostic nerve blocks is an integral part of any lameness work-up, and is therefore an essential skill for equine practitioners. However, the opportunities for veterinary students to practice this skill are limited. The aim of this study was to design and validate an equine nerve block simulator. It was hypothesised that the simulator would improve students' ability and enhance their confidence in performing nerve blocks. A simulator was built using an equine forelimb skeleton and building foam. Wire wool targets were placed under the foam in the positions corresponding to the anatomical location of the most palmar digital, abaxial and low four-point nerve blocks and attached to an electrical circuit. The circuit became complete when the operator placed a needle in the correct position and immediate audible feedback with a buzzer was provided. To validate the simulator, it was compared with two established teaching methods: cadaver training and theoretical training with a hand-out. Cadaver-trained students achieved the best results (73 per cent correct blocks), compared with simulator-trained students (71 per cent correct blocks), and a hand-out trained group (58 per cent correct blocks). Feedback obtained with a questionnaire showed that students enjoyed simulator training more, and that they felt more confident in performing diagnostic nerve blocks than the other two groups. The equine nerve block simulator provides a safe, cost-effective method to supplement the teaching of diagnostic analgesia to undergraduate veterinary students.</p>
]]></description>
<dc:creator><![CDATA[Gunning, P., Smith, A., Fox, V., Bolt, D. M., Lowe, J., Sinclair, C., Witte, T. H., Weller, R.]]></dc:creator>
<dc:date>2013-04-26T07:30:51-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101335</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101335</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Development and validation of an equine nerve block simulator to supplement practical skills training in undergraduate veterinary students]]></dc:title>
<prism:publicationDate>2013-04-27</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>17</prism:number>
<prism:startingPage>450</prism:startingPage>
<prism:endingPage>450</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/17/451?rss=1">
<title><![CDATA[An epidemiological survey on the determination of Taenia saginata cysticercosis in Iran, using a PCR assay]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/17/451?rss=1</link>
<description><![CDATA[
<p>Bovine cysticercosis caused by <I>Taenia saginata</I> is a zoonotic disease affirming routine inspection measures for the postmortem detection of cysticerci (cysts) in beef destined for human consumption. Detection is based on gross examination of traditional carcase predilection sites; although there is evidence to suggest that examination of other sites may offer improvements in sensitivity. In the current study, a biomolecular-based assay was employed to confirm and differentiate <I>T saginata</I> cysticercosis from other comparable parasitic infection in cattle carcases. Out of 7371 cattle carcases routinely inspected, 72 (0.97&nbsp;per cent) were initially detected, from which 57 (79.16 per cent), 11(15.27 per cent) and 4 (5.55 per cent) were recorded in masseter muscle, heart and diaphragm, respectively. The PCR assay was also conducted to confirm different stages of the cysts, being able to detect the cyst, and to discriminate its various degenerative stages with other parasitic structures. The technique was proposed as a reliable tool to differentiate the cysticerci and, thus, could be used in further epidemiological studies as there was no difference in view of negative PCR results in lesions found by routine inspection.</p>
]]></description>
<dc:creator><![CDATA[Hosseinzadeh, S., Setayesh, A., Shekarforoush, S. S., Fariman, S. H.]]></dc:creator>
<dc:date>2013-04-26T07:30:51-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101269</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101269</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[An epidemiological survey on the determination of Taenia saginata cysticercosis in Iran, using a PCR assay]]></dc:title>
<prism:publicationDate>2013-04-27</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>17</prism:number>
<prism:startingPage>451</prism:startingPage>
<prism:endingPage>451</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/17/452?rss=1">
<title><![CDATA[Marek's disease outbreak among vaccinated commercial layer flocks in the mining area of Karnataka, India]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/17/452?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>Marek's disease (MD) of chicken is caused by <I>Gallid herpesvirus</I> 2 belonging to the genus <I>Mardivirus</I> and family <I>Herpesviridae</I>. Annual losses due to MD the world over have been estimated to be more than 1 billion US dollars (Nair 2005). Previously, MD was reported to be a disease of younger chicken of 4&ndash;20&nbsp;weeks old, but in recent times, it has been often observed in adult flocks (Lobago and Woldemeskel 2004, Ikezawa and others 2010). Mining activities generate a lot of dust that contaminates the environment and soil (Nagajyoti and others 2010), and prolonged exposure to mine dust could cause immunosuppression in chickens (Muniyellappa and others 2012). This communication reports occurrence of various forms of MD in vaccinated commercial layer flocks in the mining areas.</p> <p>Six commercial layer poultry farms were randomly chosen in the mining area of north Karnataka. Flock details, clinical history and signs, morbidity, mortality,...]]></description>
<dc:creator><![CDATA[Muniyellappa, H. K., Satyanarayana, M. L., Isloor, S., Gowda, N. K. S.]]></dc:creator>
<dc:date>2013-04-26T07:30:51-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101203</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101203</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Marek's disease outbreak among vaccinated commercial layer flocks in the mining area of Karnataka, India]]></dc:title>
<prism:publicationDate>2013-04-27</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>17</prism:number>
<prism:startingPage>452</prism:startingPage>
<prism:endingPage>452</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/17/452-a?rss=1">
<title><![CDATA[Fibromatous lesions of antler velvet and haired skin in reindeer (Rangifer tarandus)]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/17/452-a?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>Fibromatous nodular lesions were observed on the antler skin of reindeer from four separate farms, and from the haired skin from a deer from a fifth farm. The aim of this study was to investigate if the proliferative lesions represented an unusual manifestation of a viral infection. Despite extensive investigations using immunohistochemistry, PCR and electron microscopy, no evidence of viral involvement could be demonstrated. The aetiology of the lesions remains unknown.</p> <p>Fibropapillomas are nodular or plaque-like lesions associated with papilloma virus (PV) infection; they have been observed in several deer species, including reindeer (Sundberg and Nielsen 1981, Ginn and others 2007). The histopathological findings typically include proliferation of dermal fibroblasts. Reindeer papilloma virus (RtPV1) has been detected in papillomatous lesions involving the haired skin of reindeer (Narechania and others 2004). In this report, we describe fibrous proliferation of the dermis of lesions involving the antler velvet and...]]></description>
<dc:creator><![CDATA[Foster, A. P., Barlow, A. M., Nasir, L., Wilson, C. D., Everest, D. J., Erdelyi, K., Finnegan, C. J., Schock, A.]]></dc:creator>
<dc:date>2013-04-26T07:30:51-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101499</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101499</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Fibromatous lesions of antler velvet and haired skin in reindeer (Rangifer tarandus)]]></dc:title>
<prism:publicationDate>2013-04-27</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>17</prism:number>
<prism:startingPage>452</prism:startingPage>
<prism:endingPage>452</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/16/421?rss=1">
<title><![CDATA[Science, legislation and hen welfare]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/16/421?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>IN THE past two decades there have been major changes in how farm animals are housed and managed. This is partly due to increased public awareness and interest in farm animal welfare and legislative changes. The most notable change in farm animal welfare legislation has been regarding housing for laying hens. In 1999, the EU banned the use of conventional battery cages by 2012 (Directive 1999/74/EC), resulting in a shift to alternative housing systems, such as furnished (enriched) cages, and loose-housing systems (eg, aviaries and free-range systems). Directive 1999/74/EC has been publicised as the &lsquo;most important single piece of legislation to affect poultry keeping&rsquo; (Fr&ouml;lich and others 2012), having both economical and political effects (Pritchard 2012). Similar legislative changes are slowly occurring in other countries as well. For example, conventional battery cages will be phased out in some states in the USA within the next few years...]]></description>
<dc:creator><![CDATA[Erasmus, M.]]></dc:creator>
<dc:date>2013-04-19T07:45:45-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.f2372</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.f2372</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Science, legislation and hen welfare]]></dc:title>
<prism:publicationDate>2013-04-20</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>16</prism:number>
<prism:startingPage>421</prism:startingPage>
<prism:endingPage>422</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/16/423?rss=1">
<title><![CDATA[A bespoke management package can reduce levels of injurious pecking in loose-housed laying hen flocks]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/16/423?rss=1</link>
<description><![CDATA[
<p>This study investigated the protective effects of an on-farm management package designed to reduce injurious pecking (IP) in loose-housed laying hens. A systematic review of scientific literature generated 46 potentially protective management strategies. Bespoke management packages were designed for treatment flocks (TF) using these management strategies. IP in 53 TFs was compared with IP in 47 control flocks (CF) where the management package was not employed. Scoring of plumage damage (PD) and observations of gentle and severe feather pecking (GFP; SFP), and vent and cannibalistic pecking (VP) were completed, and management strategy use was recorded, at 20, 30 and 40 weeks of age. Differences between treatment and CF were examined using multilevel modelling. Compared with CF, TF employed more management strategies (P&lt;0.001), had lower PD (P=0.003) and SFP (P=0.019). Regardless of treatment or control flock status, the more of the 46 management strategies that were employed the lower was the PD (P=0.004), GFP (P=0.021), SFP (P=0.043), mortality at 40 weeks (P=0.025), and the likelihood of VP (P=0.021). Therefore, the provision of a bespoke management package was protective against the majority of forms of IP in commercial laying hen flocks.</p>
]]></description>
<dc:creator><![CDATA[Lambton, S. L., Nicol, C. J., Friel, M., Main, D. C. J., McKinstry, J. L., Sherwin, C. M., Walton, J., Weeks, C. A.]]></dc:creator>
<dc:date>2013-04-19T07:45:46-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101067</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101067</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[A bespoke management package can reduce levels of injurious pecking in loose-housed laying hen flocks]]></dc:title>
<prism:publicationDate>2013-04-20</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>16</prism:number>
<prism:startingPage>423</prism:startingPage>
<prism:endingPage>423</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/16/424?rss=1">
<title><![CDATA[Sequence diversity of the leukotoxin (lktA) gene in caprine and ovine strains of Mannheimia haemolytica]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/16/424?rss=1</link>
<description><![CDATA[
<p><I>Mannheimia haemolytica</I> is the aetiological agent of pneumonic pasteurellosis in small ruminants. The primary virulence factor of the bacterium is a leukotoxin (LktA), which induces apoptosis in susceptible cells via mitochondrial targeting. It has been previously shown that certain <I>lktA</I> alleles are associated either with cattle or sheep. The objective of the present study was to investigate <I>lktA</I> sequence variation among ovine and caprine <I>M haemolytica</I> strains isolated from pneumonic lungs, revealing any potential adaptation for the caprine host, for which there is no available data. Furthermore, we investigated amino acid variation in the N-terminal part of the sequences and its effect on targeting mitochondria. Data analysis showed that the prevalent caprine genotype differed at a single non-synonymous site from a previously described uncommon bovine allele, whereas the ovine sequences represented new, distinct alleles. N-terminal sequence differences did not affect the mitochondrial targeting ability of the isolates; interestingly enough in one case, mitochondrial matrix targeting was indicated rather than membrane association, suggesting an alternative LktA trafficking pattern.</p>
]]></description>
<dc:creator><![CDATA[Vougidou, C., Sandalakis, V., Psaroulaki, A., Petridou, E., Ekateriniadou, L.]]></dc:creator>
<dc:date>2013-04-19T07:45:46-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101014</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101014</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Sequence diversity of the leukotoxin (lktA) gene in caprine and ovine strains of Mannheimia haemolytica]]></dc:title>
<prism:publicationDate>2013-04-20</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>16</prism:number>
<prism:startingPage>424</prism:startingPage>
<prism:endingPage>424</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/16/425?rss=1">
<title><![CDATA[Application of a single vascularised skin flap in eastern imperial eagle with skin defects]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/16/425?rss=1</link>
<description><![CDATA[
<p>Skin defects are a frequent problem in avian clinical practice. They require rapid and effective therapy due to the absence of available skin around the skin defects and desiccation of the surrounding tissue. Within the period of one year, between March 2010 and April 2011, several specimens of eastern imperial eagle (<I>Aquila heliaca</I>) were treated at the Clinic of Exotic and Free-Living Animals of the University of Veterinary Medicine and Pharmacy in Kosice. Three of them (cases 1, 2 and 3) had damaged skin on their limbs. The skin defects presented in these patients required surgical treatment by a vascularised skin flap. Acceptance of the skin flap on the entire recipient site was seen in all three patients. Complete healing, as well as functioning of the damaged sites were observed within two months from the surgery. Using surgical treatment in case of extensive skin damages, as well as skin damages in hardly accessible locations, helps to prevent a number of complications associated with the management of the treatment of open wounds. The given method appears suitable also due to a better cosmetic effect and lower degree of stress to the patients.</p>
]]></description>
<dc:creator><![CDATA[Kozar, M., Molnar, L., Trbolova, A., Kozarova, I.]]></dc:creator>
<dc:date>2013-04-19T07:45:46-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101176</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101176</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Application of a single vascularised skin flap in eastern imperial eagle with skin defects]]></dc:title>
<prism:publicationDate>2013-04-20</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>16</prism:number>
<prism:startingPage>425</prism:startingPage>
<prism:endingPage>425</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/16/426?rss=1">
<title><![CDATA[Evaluation of 3-methylhistidine levels in dogs with chronic mitral valve disease]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/16/426?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>The post-translationally modified amino acid 3-methylhistidine (3-MEH) is a component of the contractile proteins actin and myosin. The presence of 3-MEH in urine is associated with protein breakdown or nitrogen loss, as reported in laboratory rats (<cross-ref type="bib" refid="R7">Kim and Lee 1990</cross-ref>), dairy cows (Blum and others 1985, Plaizier and others 2000) and dogs under a variety of physiological conditions (Neumann and others 2008). This modified amino acid results from post-translational methylation of histidine in the t-RNA complex, which occurs only in actin and myosin. After proteolysis, it cannot be recycled (<cross-ref type="bib" refid="R20">Young and Munro 1978</cross-ref>), and therefore, it is removed as waste in the urine (Long and others 1975). Thus, there is a strong correlation between 3-MEH urinal levels and the degree of myofibrillar (contractile) protein breakdown in the absence of renal failure (<cross-ref type="bib" refid="R10">Nagabhushan and Narasingarao 1978</cross-ref>).</p> <p>Muscle wasting and weakness in humans...]]></description>
<dc:creator><![CDATA[Lee, S.-G., Hyun, C.]]></dc:creator>
<dc:date>2013-04-19T07:45:46-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101378</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101378</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Evaluation of 3-methylhistidine levels in dogs with chronic mitral valve disease]]></dc:title>
<prism:publicationDate>2013-04-20</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>16</prism:number>
<prism:startingPage>426</prism:startingPage>
<prism:endingPage>426</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/16/426-a?rss=1">
<title><![CDATA[Clinical safety of rapid sequential administration of moxidectin injection and oral derquantel-abamectin as a quarantine treatment for introduced sheep]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/16/426-a?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>In the absence of sensitive, rapid and accurate diagnostic tests for the presence of parasites in individual sheep, introduced sheep are potential sources of multiple anthelmintic-resistant nematodes and psoroptic mange (sheep scab) mites, <I>Psoroptes ovis</I> (Sargison 2011, Burgess and others 2012). Current UK guidelines recommend treatment of all introduced sheep with an effective anthelmintic and, if there is a risk that they may harbour scab mites, additional treatment with an appropriate acaricide on arrival at the farm (Abbott and others 2012). The need for such quarantine treatments applies equally to all introduced animals, including purchased sheep and sheep returning from grazing areas away from the main farm (Sargison 2011).</p> <p>A dual active formulation of derquantel (DQL) and abamectin (ABA) (STARTECT Dual Active Oral Solution for Sheep, Zoetis; DQL+ABA) was recently authorised in the UK and Ireland for the treatment of gastrointestinal nematodes in sheep including strains resistant...]]></description>
<dc:creator><![CDATA[Bartram, D. J., Noe, L., Krautmann, M. J., Lane, S., Geurden, T.]]></dc:creator>
<dc:date>2013-04-19T07:45:46-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101442</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101442</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Clinical safety of rapid sequential administration of moxidectin injection and oral derquantel-abamectin as a quarantine treatment for introduced sheep]]></dc:title>
<prism:publicationDate>2013-04-20</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>16</prism:number>
<prism:startingPage>426</prism:startingPage>
<prism:endingPage>426</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/15/393?rss=1">
<title><![CDATA[Equine grass sickness: what's new?]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/15/393?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>WRITING a science editorial regarding new aspects of equine grass sickness (EGS) is challenging at a time when we are eagerly awaiting results from vaccination trials and ongoing research, trying to identify the cause of EGS and factors involved in aetiopathogenesis.</p> <p>Britain has remained the country most affected by this often fatal neurodegenerative disease, with EGS being one of the most important threats to equine health in some areas. To collate details of clinical cases in Great Britain, a nationwide surveillance scheme has been instituted (Wylie and others 2011). Similar to the Alert group for atypical myopathy, a European epidemiosurveillance network could be initiated for EGS, because the disease has also been reported in other countries, including Cyprus, Hungary and the Czech Republic (Protopapas and others 2012, Schwarz and others 2012; personal communication, B. Bezdekova). In north eastern Hungary, young horses (two to three years old) have...]]></description>
<dc:creator><![CDATA[Schwarz, B.]]></dc:creator>
<dc:date>2013-04-12T07:00:54-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.f2191</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.f2191</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Equine grass sickness: what's new?]]></dc:title>
<prism:publicationDate>2013-04-13</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>15</prism:number>
<prism:startingPage>393</prism:startingPage>
<prism:endingPage>394</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/15/395?rss=1">
<title><![CDATA[In equine grass sickness, serum amyloid A and fibrinogen are elevated, and can aid differential diagnosis from non-inflammatory causes of colic]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/15/395?rss=1</link>
<description><![CDATA[
<p>Equine grass sickness (EGS) is a debilitating and often fatal neurodegenerative disease. A presumptive diagnosis of EGS may be made on the basis of clinical signs and subjective ancillary tests, but a definitive <I>antemortem</I> diagnosis can only be made following histopathological examination of intestinal biopsies. It has previously been reported that horses with EGS may show clinical and clinicopathological signs of systemic inflammation. The objective of this study was to (a) quantify acute inflammatory markers in blood samples collected from acute, subacute and chronic EGS cases, and (b) compare them with (i) clinically normal horses co-grazing with acute EGS cases (co-grazers), (ii) horses with other causes of colic and (iii) healthy horses. Serum amyloid A (SAA), serum activin A and plasma fibrinogen were quantified. There were marked increases in SAA and fibrinogen in EGS cases compared with healthy horses, co-grazers and non-inflammatory colic cases. The concentrations of SAA and fibrinogen in EGS cases were not significantly different from inflammatory colic cases. When concentrations of SAA, fibrinogen and activin A in each EGS subgroup were compared, no significant differences were detected. Activin A concentrations were significantly elevated in EGS cases and co-grazing horses; this could reflect the presence of subclinical disease in some horses that do not develop clinical signs of EGS, and suggests widespread exposure to the aetiological agent. When faced with sparse <I>antemortem</I> diagnostic techniques, identification of marked increases in acute phase protein concentrations may help to differentiate EGS from other causes of abdominal pain, such as intestinal obstructions; however, there could be diagnostic difficulty in differentiating other inflammatory abdominal conditions, such as peritonitis or enteritis.</p>
]]></description>
<dc:creator><![CDATA[Copas, V. E. N., Durham, A. E., Stratford, C. H., McGorum, B. C., Waggett, B., Pirie, R. S.]]></dc:creator>
<dc:date>2013-04-12T07:00:54-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101224</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101224</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[In equine grass sickness, serum amyloid A and fibrinogen are elevated, and can aid differential diagnosis from non-inflammatory causes of colic]]></dc:title>
<prism:publicationDate>2013-04-13</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>15</prism:number>
<prism:startingPage>395</prism:startingPage>
<prism:endingPage>395</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/15/396?rss=1">
<title><![CDATA[Evaluation of intraocular pressure in conscious ferrets (Mustela putorius furo) by means of rebound tonometry and comparison with applanation tonometry]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/15/396?rss=1</link>
<description><![CDATA[
<p>To determine normal intraocular pressure (IOP) values by means of rebound tonometry in unanaesthetised ferrets, and to compare rebound and applanation tonometry, 55 clinically healthy ferrets were included in an observational, prospective, blinded study. On 52 ferrets, IOP was measured by means of rebound and applanation tonometry. On 3 ferrets, rebound tonometry was performed every two hours over a 24-hour period. Mean IOPs of the 104 eyes obtained with the rebound tonometer were 14.07&plusmn;0.35 (95% CI 13.37 to 14.77) tonometer-units (TU). The IOP was significantly higher in males than in females, controlling for age and weight. A study-ordered decrease in coefficient of variation (CV) was observed (measurement 1&ndash;52=21.2&plusmn;1.4 per cent v measurement 53&ndash;104=14.4&plusmn;1.1 per cent) and high CVs (&gt;30 per cent) were significantly less frequent in measurement 53&ndash;104. A significant difference in IOP during the 24-&nbsp;hour measurements was found, with the lowest IOP recorded at 22:00. The tonometers presented poor agreement, and IOP values were not correlated. The difference in IOP estimation increased with the magnitude of the measurements. Applanation tonometry presented a significant higher frequency of per-eye IOP values exceeding 25 and 30 TU, and a significant lower repeatability (CV=37.1&plusmn;2.6 per cent v 17.8&plusmn;1.2 per cent) compared with rebound tonometry. In conclusion, several factors need to be considered when measuring IOP in ferrets.</p>
]]></description>
<dc:creator><![CDATA[Di Girolamo, N., Andreani, V., Guandalini, A., Selleri, P.]]></dc:creator>
<dc:date>2013-04-12T07:00:54-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101086</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101086</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Evaluation of intraocular pressure in conscious ferrets (Mustela putorius furo) by means of rebound tonometry and comparison with applanation tonometry]]></dc:title>
<prism:publicationDate>2013-04-13</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>15</prism:number>
<prism:startingPage>396</prism:startingPage>
<prism:endingPage>396</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/15/397?rss=1">
<title><![CDATA[Presence of Clostridium botulinum and botulinum toxin in milk and udder tissue of dairy cows with suspected botulism]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/15/397?rss=1</link>
<description><![CDATA[
<p>Clostridium botulinum is an anaerobic spore-forming bacterium prevalent in the environment, and causes botulism in man and animals via toxins. Dairy cattle may be contaminated or infected by feed, water or other environmental factors. Milk may also carry the pathogen. Hence, milk and udder samples need to be tested. The number of clinical cases of bovine botulism in Germany has been increasing since the mid-1990s. Besides routine samples, additional 99 milk samples from 37 farms, and 51 udder samples from 51 farms from sick animals presumably affected by botulism were tested microbiologically by the mouse bioassay. Milk from three farms (8.1 per cent) contained botulinum toxin, and from two (5.4 per cent) bacterial states of C botulinum. Ten udder samples (19.6 per cent) contained toxin, and 7 (13.7 per cent) bacterial forms, including one case where both toxin and bacteria were found. The findings are discussed. Positive milk samples containing botulinum toxin or bacteria raise concern of food safety for the human consumer. Pathological udder samples may show either infection prior to, or contamination after death.</p>
]]></description>
<dc:creator><![CDATA[Bohnel, H., Gessler, F.]]></dc:creator>
<dc:date>2013-04-12T07:00:54-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.100418</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.100418</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Presence of Clostridium botulinum and botulinum toxin in milk and udder tissue of dairy cows with suspected botulism]]></dc:title>
<prism:publicationDate>2013-04-13</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>15</prism:number>
<prism:startingPage>397</prism:startingPage>
<prism:endingPage>397</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/15/398?rss=1">
<title><![CDATA[The use of wild animal models to detect evidence of environmental contamination by asbestos-like substance]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/15/398?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>Environmental contamination by asbestos, obtained by mineral extraction for its use in buildings and industrial activity, still represents one of the health priorities of modern times (Bruno and others 2007). Asbestos-related risks and its implications in human disease, such as mesothelioma and similar conditions, are still controversial. In 2004, epidemiological studies revealed an unexpected high prevalence of pleural mesothelioma in human beings of Biancavilla village in Catania, a small town at the foot of Mount Etna (Biggeri and others 2004). This discovery provoked the public health authorities to investigate the environmental risk in the area. The source of the problem was identified as a local open-pit mine located near Monte Calvario, which had been used over the last century as a source of concrete-pozzolan sand for buildings in the town. Materials extracted from the quarry were incorporated into walls and frames of many old houses. Chemical studies...]]></description>
<dc:creator><![CDATA[Puleio, R., Schiavo, M. R., Macaluso, G., Manno, C., Loria, G. R.]]></dc:creator>
<dc:date>2013-04-12T07:00:54-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101365</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101365</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[The use of wild animal models to detect evidence of environmental contamination by asbestos-like substance]]></dc:title>
<prism:publicationDate>2013-04-13</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>15</prism:number>
<prism:startingPage>398</prism:startingPage>
<prism:endingPage>398</prism:endingPage>
</item>
<item rdf:about="http://veterinaryrecord.bmj.com/cgi/content/short/172/15/398-a?rss=1">
<title><![CDATA[Foal immunodeficiency syndrome: carrier testing has markedly reduced disease incidence]]></title>
<link>http://veterinaryrecord.bmj.com/cgi/content/short/172/15/398-a?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>Foal immunodeficiency syndrome (FIS), a fatal autosomal recessive disease found in three breeds of horses, was first reported (in the Fell pony) in 1996, and it soon became apparent that significant numbers of syndrome foals were being born each year. In each FIS case, the foals are clinically normal at birth, but start to weaken at 2&ndash;8&nbsp;weeks (Scholes and others 1998) as they develop profound anaemia (Dixon and others 2000) and do not have the ability to produce their own antibodies (Thomas and others 2005), due to the almost total lack of B lymphocytes in the circulation or tissues (Thomas and others 2003), but with apparently normal levels of functional T lymphocytes (Bell and others 2001). The outcome is persistent opportunistic infections with no effective treatment; euthanasia is the preferred option. FIS has also been reported in Fell ponies in The Netherlands (Butler and others 2006), Germany...]]></description>
<dc:creator><![CDATA[Carter, S. D., Fox-Clipsham, L. Y., Christley, R., Swinburne, J.]]></dc:creator>
<dc:date>2013-04-12T07:00:54-07:00</dc:date>
<dc:identifier>info:doi/10.1136/vr.101451</dc:identifier>
<dc:identifier>hwp:master-id:vetrec;vr.101451</dc:identifier>
<dc:publisher>British Veterinary Association</dc:publisher>
<dc:title><![CDATA[Foal immunodeficiency syndrome: carrier testing has markedly reduced disease incidence]]></dc:title>
<prism:publicationDate>2013-04-13</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>172</prism:volume>
<prism:number>15</prism:number>
<prism:startingPage>398</prism:startingPage>
<prism:endingPage>398</prism:endingPage>
</item>
</rdf:RDF>